arrow_back Back to App

Strengthening US Drug Production: New Technologies and Centers of Excellence.

This act aims to enhance drug supply security in the US by supporting advanced pharmaceutical manufacturing technologies. Citizens can expect fewer drug shortages and faster access to innovative therapies, improving the availability of critical medications in daily life and during crises.
Key points
Support for new drug manufacturing technologies to prevent shortages and ensure consistent supply.
Establishment of national centers of excellence in pharmaceutical manufacturing to foster innovation and train future professionals.
Expediting the approval process for innovative drug manufacturing methods by the Food and Drug Administration (FDA).
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_70
Sponsor: Rep. Buchanan, Vern [R-FL-16]
Process start date: 2021-01-04
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Securing America’s Medicine Cabinet Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_70.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-01-04.

What are the main provisions?

Key points include:

  • Support for new drug manufacturing technologies to prevent shortages and ensure consistent supply.
  • Establishment of national centers of excellence in pharmaceutical manufacturing to foster innovation and train future professionals.
  • Expediting the approval process for innovative drug manufacturing methods by the Food and Drug Administration (FDA).
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Buchanan, Vern [R-FL-16].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health Public Investments Economy